Lanchbury J S, Jaeger E E, Sansom D M, Hall M A, Wordsworth P, Stedeford J, Bell J I, Panayi G S
Molecular Immunogenetics Unit, UMDS, Guy's Hospital, London, United Kingdom.
Hum Immunol. 1991 Sep;32(1):56-64. doi: 10.1016/0198-8859(91)90117-r.
Felty's syndrome (FS) is a rare complication of rheumatoid arthritis (RA) previously shown to be strongly associated with HLA-DR4 and less significantly with HLA-DQw7. To map more precisely the HLA locus responsible for susceptibility to FS, we have examined HLA-DR4 and DQ beta-chain polymorphisms in FS patients and controls using restriction fragment length polymorphism analysis and polymerase chain reaction amplification in conjunction with oligonucleotide probing. The increased frequency of DR4 in FS (93% vs. 32% controls) was due almost entirely to enrichment for the Dw4 subtype (88% vs. 20% controls) with a secondary increase of the Dw14 subtype. Dw10 and Dw13 subtypes of DR4 were absent from the patient group. Increase in DQw7 frequency among DR4 FS patients could be accounted for by linkage disequilibrium between Dw4 and DQw7 alleles. Whereas susceptibility to RA is strongly associated with a conserved HLA-DR beta epitope associated with several DRB1 alleles, it is primarily the Dw4 allele which is associated with progression to Felty's syndrome. The finding that amino acid sequence variation at the DR4B1 locus rather than DQB1 is associated with development of FS will have important implications for the development of novel immunotherapies which are major histocompatibility complex allele-dependent.
费尔蒂综合征(FS)是类风湿关节炎(RA)的一种罕见并发症,此前已证明其与HLA - DR4密切相关,与HLA - DQw7的相关性较弱。为了更精确地定位与FS易感性相关的HLA基因座,我们使用限制性片段长度多态性分析和聚合酶链反应扩增结合寡核苷酸探针,检测了FS患者和对照组中的HLA - DR4和DQβ链多态性。FS中DR4频率的增加(93%对32%的对照组)几乎完全归因于Dw4亚型的富集(88%对20%的对照组),同时Dw14亚型也有次要增加。患者组中不存在DR4的Dw10和Dw13亚型。DR4 FS患者中DQw7频率的增加可由Dw4和DQw7等位基因之间的连锁不平衡来解释。虽然RA的易感性与与几个DRB1等位基因相关的保守HLA - DRβ表位密切相关,但主要是Dw4等位基因与进展为费尔蒂综合征相关。DRB1基因座而非DQB1基因座的氨基酸序列变异与FS的发生相关这一发现,将对依赖主要组织相容性复合体等位基因的新型免疫疗法的开发产生重要影响。